AEENA Dx

AEENA Dx was a private molecular diagnostics company based in Mountain View, California, developing a non-invasive saliva-based platform for the detection of cancer and other diseases. The company appears to have originated as Prime Genomics and later operated as AEENA Dx, with a core focus on genomics-based, salivary diagnostics and an early emphasis on breast cancer detection. Publicly available materials describe proprietary saliva collection and analysis technology intended for scalable, broad disease detection in clinical and point-of-care settings. In 2023, AEENA Dx merged with NOWDiagnostics, and the combined company continued under the NOWDiagnostics name. As a result, AEENA Dx should be viewed as an acquired/merged diagnostics company rather than an independent standalone operating business today.